Diversify Advisory Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Diversify Advisory Services’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$415K	Sell	981 -6,146	-86%	-$2.87M	0.06%	130
2025 Q4	$3.15M	Sell	7,127 -183	-3%	-$78.9K	0.1%	155
2025 Q3	$3.11M	Buy	7,310 +19	+0.3%	+$7.94K	0.1%	150
2025 Q2	$2.83M	Buy	7,291 +1,518	+26%	+$700K	0.11%	140
2025 Q1	$2.91M	Buy	5,773 +827	+17%	+$385K	0.18%	90
2024 Q4	$2.03M	Buy	4,946 +131	+3%	+$60.7K	0.11%	131
2024 Q3	$2.29M	Sell	4,815 -501	-9%	-$241K	0.12%	150
2024 Q2	$2.58M	Sell	5,316 -336	-6%	-$146K	0.14%	128
2024 Q1	$2.38M	Buy	+5,652	New	+$2.39M	0.14%	145

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Diversify Advisory Services's VRTX Position: Q1 2026 in Review

Diversify Advisory Services reduced its Vertex Pharmaceuticals (VRTX) stake by 86% in Q1 2026, selling an estimated $2.87M and leaving 981 shares worth $415K. The position accounts for 0.06% of the portfolio, ranked #130.

Diversify Advisory Services first reported a position in VRTX in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.15M in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Diversify Advisory Services held 981 shares of Vertex Pharmaceuticals worth $415K as of Q1 2026.
Diversify Advisory Services sold 6,146 Vertex Pharmaceuticals shares in Q1 2026, an estimated $2.87M.
Vertex Pharmaceuticals made up 0.06% of Diversify Advisory Services's portfolio in Q1 2026, its #130 holding.
Diversify Advisory Services first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
Diversify Advisory Services's Vertex Pharmaceuticals position peaked at $3.15M in Q4 2025.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Diversify Advisory Services's 13F filing for Q1 2026, filed 4 May 2026.